What is Charles & Colvard Ltd's earnings per share (EPS)?

Charles & Colvard Ltd (CTHR) reported diluted earnings per share of -$4.73 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Charles & Colvard Ltd Financials

CTHR

Trailing 12 months to March 31, 2025

Revenue $15.7M -33.5% YoY

Net Income -$12.0M +34.6% YoY

EPS (Diluted) -$3.87 YoY not available

Free Cash Flow -$7.0M +2.8% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Mar 31, 2025 Reported Aug 4, 2025 Currency USD FYE June

Charles & Colvard Ltd (CTHR) reported $15.7M in revenue over the twelve months to Mar 31, 2025, down 33.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CTHR FY2024 2026-08-30

Shrinking sales are colliding with a cost base that has not contracted, turning gross-margin recovery into deeper cash consumption.

The gross margin rebounded to 23.7% in FY2024 from 15.8% in FY2023. Yet operating margin fell to -66.5% while SG&A reached $5.8M; margin improvement therefore did not overcome a largely fixed cost burden.

Operating cash flow of -$7.4M accompanied the latest net loss of -$14.4M, so the earnings shortfall was also a cash event. Free cash flow of -$8.3M exceeded capital expenditures of $954K in absolute terms, indicating that cash pressure extended beyond reinvestment.

Current ratio fell from 3.4x in FY2023 to 1.3x in FY2024, reducing working-capital cushion as liabilities increased. The reported liquidity measure was 6.7 months of the latest annual operating outflow, while financing cash flow was $2.3M; balance-sheet support was not solely generated by current operations.

Financial Health Signals

Financial health score not available

Charles & Colvard Ltd does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

4/8

Charles & Colvard Ltd passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Charles & Colvard Ltd reported a net loss of $14.4M while operations used $7.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Charles & Colvard Ltd reported an operating loss of $14.6M against $58K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$22.0M

YoY-26.7%

5Y CAGR-7.4%

10Y CAGR-2.6%

Charles & Colvard Ltd generated $22.0M in revenue in fiscal year 2024. This represents a decrease of 26.7% from the prior year.

EBITDA

-$13.9M

YoY-4.4%

Charles & Colvard Ltd's EBITDA was -$13.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 4.4% from the prior year.

Net Income

-$14.4M

YoY+26.6%

Charles & Colvard Ltd reported -$14.4M in net income in fiscal year 2024. This represents an increase of 26.6% from the prior year.

EPS (Diluted)

-$4.73

Charles & Colvard Ltd earned -$4.73 per diluted share (EPS) in fiscal year 2024.

Cash & Balance Sheet

Free Cash Flow

-$8.3M

YoY-63.0%

Charles & Colvard Ltd recorded an outflow of $8.3M in free cash flow in fiscal year 2024, representing a cash shortfall after capex. This represents a decrease of 63.0% from the prior year.

Cash & Debt

$4.1M

YoY-60.4%

5Y CAGR-19.8%

10Y CAGR+4.9%

Charles & Colvard Ltd held $4.1M in cash as of fiscal year 2024; long-term debt is not reported for that period.

Shares Outstanding

Charles & Colvard Ltd had 3M shares outstanding in fiscal year 2024.

Dividends Per Share

Not reported for fiscal year 2024.

Margins & Returns

Gross Margin

23.6%

YoY+7.8pp

5Y CAGR-22.5pp

10Y CAGR-30.9pp

Charles & Colvard Ltd's gross margin was 23.6% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 7.8 percentage points from the prior year.

Operating Margin

-66.5%

YoY-19.9pp

5Y CAGR-73.6pp

10Y CAGR-61.0pp

Charles & Colvard Ltd's operating margin was -66.5% in fiscal year 2024, reflecting core business profitability. This is down 19.9 percentage points from the prior year.

Net Margin

-65.4%

YoY0.0pp

5Y CAGR-72.5pp

10Y CAGR-60.9pp

Charles & Colvard Ltd's net profit margin was -65.4% in fiscal year 2024, showing the share of revenue converted to profit. That is unchanged from the prior year.

Return on Equity

-56.0%

YoY-6.8pp

5Y CAGR-60.9pp

10Y CAGR-53.8pp

Charles & Colvard Ltd's ROE was -56.0% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 6.8 percentage points from the prior year.

Capital Allocation

Share Buybacks

YoY-100.0%

Charles & Colvard Ltd repurchased no shares in fiscal year 2024. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

$954K

YoY-22.4%

5Y CAGR+21.4%

10Y CAGR+1.8%

Charles & Colvard Ltd invested $954K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 22.4% from the prior year.

R&D Spending

Not reported for fiscal year 2024.

CTHR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CTHR quarterly income statement

Metric	TTM	FY24	FY23	FY22	FY21	FY20	FY19	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Revenue	$15.7M	$22.0M-26.7%	$29.9M-30.5%	$43.1M+9.8%	$39.2M+34.4%	$29.2M-9.5%	$32.2M	$27.0M-7.3%	$29.2M+13.5%	$25.7M+0.2%	$25.6M-10.0%	$28.5M+26.9%	$22.5M+40.0%	$16.0M+26.4%	$12.7M
Cost of Revenue	$13.1M	$16.8M-33.5%	$25.2M+10.4%	$22.8M+9.8%	$20.8M-1.8%	$21.2M+22.2%	$17.4M	$15.5M-24.2%	$20.4M+7.7%	$18.9M+5.2%	$18.0M+23.4%	$14.6M+46.4%	$10.0M+53.2%	$6.5M+34.9%	$4.8M
Gross Profit	$2.6M	$5.2M+9.7%	$4.7M-76.6%	$20.2M+9.9%	$18.4M+130.6%	$8.0M-46.4%	$14.9M	$11.6M+31.9%	$8.8M-36.3%	$13.8M+42.7%	$9.6M-37.9%	$15.5M+9.6%	$14.2M+41.3%	$10.0M+27.6%	$7.9M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$2K	$4K+30.4%	$3K-84.0%	$18K-1.5%	$18K-27.4%	$25K+46.4%	$17K-88.3%	$146K+45.9%	$100K
SG&A Expenses	$5.1M	$5.8M+15.0%	$5.0M+1.5%	$4.9M+11.4%	$4.4M-8.6%	$4.9M+4.8%	$4.6M	$4.7M-15.4%	$5.5M-8.1%	$6.0M-11.2%	$6.8M+24.0%	$5.5M+15.1%	$4.8M+1.8%	$4.7M+3.2%	$4.5M
Operating Income	-$12.0M	-$14.6M-4.5%	-$14.0M-586.4%	$2.9M-47.8%	$5.5M+187.2%	-$6.3M-378.8%	$2.3M	-$609K+84.5%	-$3.9M+22.3%	-$5.1M+44.0%	-$9.0M-472.3%	-$1.6M-708.8%	$260K-80.0%	$1.3M+4.6%	$1.2M
Interest Expense	$138K	$58K	$0	$0-100.0%	$9K+912.8%	$884-59.8%	$2K	$541-68.9%	$2K-83.2%	$10K+1049.7%	$901-57.2%	$2K+67.1%	$1K+10.4%	$1K-59.7%	$3K
Income Tax	$0	$0-100.0%	$5.9M+1038.2%	$519K+108.2%	-$6.3M-365502.3%	$2K+220.1%	-$1K	$28K+104.8%	$13K+5.1%	$13K-99.7%	$4.1M+1604.7%	-$269K+93.4%	-$4.0M-2101.6%	-$184K+21.5%	-$234K
Net Income	-$12.0M	-$14.4M+26.6%	-$19.6M-924.8%	$2.4M-81.5%	$12.8M+307.9%	-$6.2M-370.8%	$2.3M	-$453K+90.0%	-$4.5M+52.7%	-$9.6M+26.9%	-$13.1M-914.4%	-$1.3M-129.5%	$4.4M+179.2%	$1.6M+0.7%	$1.6M
EPS (Diluted)	-$3.87	-$4.73	-$6.45	$0.08-81.0%	$0.42+290.9%	-$0.22-320.0%	$0.10	-$0.02+90.9%	-$0.22+53.2%	-$0.47+27.7%	-$0.65-983.3%	-$0.06-127.3%	$0.22+175.0%	$0.080.0%	$0.08

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	$4.0M-12.5%	$4.6M+43.2%	$3.2M-15.7%	$3.8M-27.1%	$5.3M-33.4%	$7.9M+59.6%	$5.0M-11.0%	$5.6M
Cost of Revenue	$3.1M-0.2%	$3.1M+40.0%	$2.2M-51.8%	$4.6M+13.6%	$4.1M-19.3%	$5.0M+67.9%	$3.0M-71.5%	$10.6M
Gross Profit	$931K-38.1%	$1.5M+50.3%	$1.0M+226.1%	-$794K-166.9%	$1.2M-58.5%	$2.9M+46.9%	$1.9M+138.9%	-$5.0M
SG&A Expenses	$1.4M+8.1%	$1.3M+0.7%	$1.3M+2.9%	$1.2M+2.2%	$1.2M-19.9%	$1.5M-19.3%	$1.9M+35.4%	$1.4M
Operating Income	-$2.0M+22.5%	-$2.5M-18.7%	-$2.1M+59.9%	-$5.3M-44.4%	-$3.7M-25.9%	-$2.9M-11.6%	-$2.6M+71.8%	-$9.3M
Interest Expense	$21K-40.8%	$36K-7.6%	$39K-10.5%	$43K+372.9%	$9K+63.4%	$6K	$0	N/A
Income Tax	$0	$0	$0	$0	$0	$0	$0-100.0%	$44K
Net Income	-$2.0M+22.2%	-$2.5M-18.9%	-$2.1M+59.9%	-$5.3M-46.6%	-$3.6M-26.8%	-$2.9M-12.9%	-$2.5M+72.6%	-$9.3M
EPS (Diluted)	-$0.63+22.2%	-$0.81-19.1%	-$0.68+61.1%	-$1.75	-$1.20-27.7%	-$0.94-13.3%	-$0.83	-$0.30

Not reported in any period shown, so not listed: R&D Expenses.

CTHR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CTHR quarterly balance sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Total Assets	$41.0M-16.4%	$49.0M-29.1%	$69.2M+6.6%	$64.9M+32.8%	$48.9M-4.4%	$51.1M	$41.2M+1.8%	$40.5M-8.2%	$44.1M-14.2%	$51.4M-17.5%	$62.3M+4.1%	$59.9M+11.6%	$53.6M+5.4%	$50.9M
Current Assets	$18.8M-23.9%	$24.7M-31.0%	$35.9M+0.3%	$35.8M+49.6%	$23.9M-14.2%	$27.9M	$20.1M-2.5%	$20.7M+0.1%	$20.7M-11.9%	$23.4M-16.4%	$28.0M-9.2%	$30.9M+54.1%	$20.0M+10.2%	$18.2M
Cash & Equivalents	$4.1M-60.4%	$10.4M-33.3%	$15.7M-26.4%	$21.3M+52.2%	$14.0M+12.3%	$12.5M	$4.6M-38.1%	$7.4M+40.8%	$5.3M+31.6%	$4.0M+55.7%	$2.6M-78.3%	$11.9M+77.0%	$6.7M-13.4%	$7.7M
Inventory	$7.5M+0.4%	$7.5M-32.2%	$11.0M-3.7%	$11.5M+53.8%	$7.4M-37.5%	$11.9M	$11.2M+14.7%	$9.8M-9.0%	$10.7M-19.4%	$13.3M+1.9%	$13.1M+54.9%	$8.4M+23.3%	$6.8M+8.6%	$6.3M
Accounts Receivable	$845K+56.4%	$540K-75.5%	$2.2M+32.4%	$1.7M+147.8%	$671K-65.8%	$2.0M	$3.4M+20.9%	$2.8M-27.5%	$3.9M-30.1%	$5.5M-46.2%	$10.2M+25.9%	$8.1M+34.2%	$6.1M+64.8%	$3.7M
Total Liabilities	$15.3M+65.4%	$9.3M-4.0%	$9.7M+4.5%	$9.2M+23.6%	$7.5M+51.2%	$4.9M	$6.4M+13.0%	$5.6M-2.0%	$5.8M+6.4%	$5.4M+10.5%	$4.9M+49.7%	$3.3M+26.0%	$2.6M+23.5%	$2.1M
Current Liabilities	$14.1M+95.6%	$7.2M+6.1%	$6.8M+21.0%	$5.6M-13.3%	$6.5M+38.1%	$4.7M	$5.4M+18.2%	$4.6M-0.3%	$4.6M+10.3%	$4.2M-6.9%	$4.5M+55.9%	$2.9M+55.6%	$1.9M+59.3%	$1.2M
Long-Term Debt	N/A	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$25.6M-35.5%	$39.8M-33.2%	$59.6M+6.9%	$55.7M+34.4%	$41.4M-10.3%	$46.2M	$34.9M0.0%	$34.9M-9.2%	$38.4M-16.6%	$46.0M-19.9%	$57.4M+1.5%	$56.6M+10.9%	$51.1M+4.6%	$48.8M
Retained Earnings	-$57.5M-33.3%	-$43.2M-83.0%	-$23.6M+9.1%	-$26.0M+33.0%	-$38.8M-18.9%	-$32.6M	-$34.1M-1.3%	-$33.7M-15.5%	-$29.1M-48.9%	-$19.6M-202.7%	-$6.5M-25.0%	-$5.2M+45.8%	-$9.5M+14.1%	-$11.1M

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$29.1M-20.5%	$36.6M-3.0%	$37.8M-7.8%	$41.0M0.0%	$41.0M-7.9%	$44.5M-4.6%	$46.6M-5.0%	$49.0M
Current Assets	$9.0M-40.1%	$15.1M-5.0%	$15.9M-15.6%	$18.8M-11.6%	$21.3M-10.1%	$23.7M+4.8%	$22.6M-8.6%	$24.7M
Cash & Equivalents	$1.3M-17.3%	$1.5M-44.5%	$2.7M-33.8%	$4.1M+12.2%	$3.7M-36.1%	$5.8M-24.0%	$7.6M-27.3%	$10.4M
Inventory	$6.0M+0.8%	$5.9M-0.1%	$5.9M-21.3%	$7.5M-28.1%	$10.4M+5.7%	$9.9M+19.6%	$8.3M+10.5%	$7.5M
Accounts Receivable	$707K-44.0%	$1.3M+45.3%	$870K+3.0%	$845K+49.1%	$567K-62.9%	$1.5M+245.3%	$443K-18.0%	$540K
Total Liabilities	$10.0M-35.7%	$15.6M+9.6%	$14.2M-7.3%	$15.3M+52.7%	$10.0M+0.6%	$10.0M+7.2%	$9.3M+0.4%	$9.3M
Current Liabilities	$9.5M-36.0%	$14.8M+12.0%	$13.2M-6.4%	$14.1M+63.9%	$8.6M+3.3%	$8.3M+11.8%	$7.5M+3.4%	$7.2M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	$0	$0	$0
Total Equity	$19.1M-9.3%	$21.1M-10.6%	$23.6M-8.1%	$25.6M-17.1%	$30.9M-10.3%	$34.5M-7.5%	$37.3M-6.3%	$39.8M
Retained Earnings	-$64.2M-3.2%	-$62.2M-4.3%	-$59.7M-3.7%	-$57.5M-10.2%	-$52.2M-7.5%	-$48.6M-6.3%	-$45.7M-5.9%	-$43.2M

Not reported in any period shown, so not listed: Goodwill.

CTHR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CTHR quarterly cash flow statement

Metric	TTM	FY24	FY23	FY22	FY21	FY20	FY19	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Operating Cash Flow	-$6.5M	-$7.4M-90.1%	-$3.9M-776.8%	$573K-91.2%	$6.5M+2497.7%	$249K-72.8%	$917K	-$2.6M-215.9%	$2.2M+40.9%	$1.6M-23.0%	$2.0M+121.9%	-$9.3M-434.4%	$2.8M-19.3%	$3.5M+132.8%	$1.5M
Capital Expenditures	$438K	$954K-22.4%	$1.2M-17.8%	$1.5M+242.4%	$437K-4.7%	$459K+27.0%	$361K	$271K-35.7%	$422K+3.5%	$407K-25.3%	$546K-31.8%	$800K-7.9%	$869K-37.3%	$1.4M+461.6%	$247K
Free Cash Flow	-$7.0M	-$8.3M-63.0%	-$5.1M-452.5%	-$924K-115.3%	$6.0M+2978.8%	-$210K-137.8%	$555K	-$2.8M-258.4%	$1.8M+54.0%	$1.2M-22.1%	$1.5M+114.7%	-$10.1M-627.8%	$1.9M-7.3%	$2.1M+67.2%	$1.2M
Investing Cash Flow	-$499K	-$1.0M+19.1%	-$1.3M+17.8%	-$1.6M-112.8%	-$733K-36.8%	-$536K-25.9%	-$426K	-$273K-366.8%	-$58K+87.7%	-$474K	N/A	-$411K-118.5%	$2.2M+153.0%	-$4.2M-210.8%	-$1.3M
Financing Cash Flow	N/A	$2.3M+609.1%	-$452K-162.7%	$720K-33.9%	$1.1M-42.6%	$1.9M-79.2%	$9.1M	$0-100.0%	$2K	N/A	N/A	$435K+174.5%	$158K+151.6%	-$307K-260.1%	$192K
Share Buybacks	N/A	$0-100.0%	$452K+1083.9%	$38K	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$354K	$0

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	-$2.8M-156.2%	-$1.1M+14.2%	-$1.3M+1.6%	-$1.3M+38.0%	-$2.1M-65.1%	-$1.3M+52.0%	-$2.7M-5497.1%	-$48K
Capital Expenditures	$44K-34.8%	$67K-30.4%	$97K-58.0%	$230K+1.0%	$228K-18.1%	$278K+28.2%	$217K-37.2%	$346K
Free Cash Flow	-$2.9M-145.2%	-$1.2M+15.3%	-$1.4M+10.0%	-$1.5M+34.2%	-$2.3M-50.2%	-$1.6M+46.0%	-$2.9M-633.1%	-$393K
Investing Cash Flow	-$53K+28.6%	-$74K+30.0%	-$106K+60.0%	-$265K-12.6%	-$236K+22.9%	-$305K-31.9%	-$232K+34.6%	-$354K
Financing Cash Flow	-$2.3M	N/A	N/A	$1.8M+260.0%	$500K	$0	$0	$0
Share Buybacks	N/A	N/A	N/A	$0	$0	$0	$0	$0

Not reported in any period shown, so not listed: Dividends Paid.

CTHR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

CTHR quarterly financial ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Gross Margin	23.6%+7.8pp	15.8%-31.2pp	47.0%0.0pp	47.0%+19.6pp	27.4%-18.8pp	46.2%	42.8%+12.7pp	30.1%-23.5pp	53.6%+16.0pp	37.6%-16.9pp	54.6%-8.6pp	63.1%+0.6pp	62.6%+0.6pp	62.0%
Operating Margin	-66.5%-19.9pp	-46.7%-53.3pp	6.7%-7.4pp	14.0%+35.7pp	-21.6%-28.7pp	7.0%	-2.3%+11.3pp	-13.5%+6.2pp	-19.7%+15.6pp	-35.3%-29.7pp	-5.5%-6.7pp	1.2%-6.9pp	8.1%-1.7pp	9.8%
Net Margin	-65.4%0.0pp	-65.4%-70.9pp	5.5%-27.1pp	32.6%+53.8pp	-21.1%-28.2pp	7.1%	-1.7%+13.8pp	-15.5%+21.7pp	-37.3%+13.8pp	-51.1%-46.6pp	-4.5%-24.0pp	19.5%+9.7pp	9.8%-2.5pp	12.3%
Return on Equity	-56.0%-6.8pp	-49.2%-53.2pp	4.0%-19.0pp	23.0%+37.9pp	-14.9%-19.8pp	4.9%	-1.3%+11.7pp	-13.0%+12.0pp	-24.9%+3.5pp	-28.5%-26.2pp	-2.3%-10.0pp	7.7%+4.7pp	3.1%-0.1pp	3.2%
Return on Assets	-35.0%+4.9pp	-39.9%-43.4pp	3.4%-16.3pp	19.7%+32.3pp	-12.6%-17.0pp	4.5%	-1.1%+10.1pp	-11.2%+10.5pp	-21.7%+3.8pp	-25.5%-23.4pp	-2.1%-9.4pp	7.3%+4.4pp	2.9%-0.1pp	3.1%
Current Ratio	1.33-2.1x	3.43-1.8x	5.27-1.1x	6.36+2.7x	3.69-2.2x	5.93	3.70-0.8x	4.490.0x	4.47-1.1x	5.59-0.6x	6.23-4.5x	10.70-0.1x	10.81-4.8x	15.61
Debt-to-Equity	0.60+0.6x	0.00-0.2x	0.160.0x	0.170.0x	0.18+0.1x	0.11	0.180.0x	0.160.0x	0.150.0x	0.120.0x	0.090.0x	0.060.0x	0.050.0x	0.04
FCF Margin	-37.9%-20.8pp	-17.1%-14.9pp	-2.1%-17.5pp	15.4%+16.1pp	-0.7%-2.4pp	1.7%	-10.5%-16.6pp	6.1%+1.6pp	4.5%-1.3pp	5.8%+41.3pp	-35.5%-44.0pp	8.5%-4.4pp	12.9%+3.1pp	9.8%

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	23.0%-9.5pp	32.5%+1.6pp	31.0%+51.6pp	-20.7%-43.2pp	22.5%-13.6pp	36.1%-3.1pp	39.3%+129.1pp	-89.8%
Operating Margin	-48.6%+6.3pp	-54.9%+11.3pp	-66.1%	-139.2%	-70.3%-33.1pp	-37.2%+16.0pp	-53.1%	-167.8%
Net Margin	-48.7%+6.1pp	-54.8%+11.2pp	-66.0%	-138.8%	-69.0%-32.8pp	-36.3%+15.0pp	-51.3%	-166.3%
Return on Equity	-10.3%+1.7pp	-12.0%-3.0pp	-9.1%+11.7pp	-20.8%-9.0pp	-11.8%-3.4pp	-8.3%-1.5pp	-6.8%+16.5pp	-23.3%
Return on Assets	-6.8%+0.1pp	-6.9%-1.3pp	-5.7%+7.3pp	-13.0%-4.1pp	-8.9%-2.4pp	-6.5%-1.0pp	-5.5%+13.4pp	-18.9%
Current Ratio	0.95-0.1x	1.02-0.2x	1.20-0.1x	1.33-1.1x	2.47-0.4x	2.84-0.2x	3.03-0.4x	3.43
Debt-to-Equity	0.52-0.2x	0.74+0.1x	0.600.0x	0.60+0.3x	0.32+0.3x	0.000.0x	0.000.0x	0.00
FCF Margin	-71.0%-45.7pp	-25.3%+17.5pp	-42.8%-2.7pp	-40.1%+4.3pp	-44.5%-24.8pp	-19.7%+38.5pp	-58.2%-51.1pp	-7.1%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Similar Companies

Mene MENEF

$29.2M

Adamas One Corp JEWL

$8.4M

Bergio Internati BRGO

$290K

Maison Luxe Inc MASN

$193K

Rivalry RVLCF

$236K

Where Charles & Colvard Ltd Ranks

Frequently Asked Questions

What is Charles & Colvard Ltd's annual revenue?

Charles & Colvard Ltd (CTHR) reported $22.0M in total revenue for fiscal year 2024. This represents a -26.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Charles & Colvard Ltd's revenue growing?

Charles & Colvard Ltd (CTHR) revenue declined by 26.7% year-over-year, from $29.9M to $22.0M in fiscal year 2024.

Is Charles & Colvard Ltd profitable?

No, Charles & Colvard Ltd (CTHR) reported a net income of -$14.4M in fiscal year 2024, with a net profit margin of -65.4%.

What is Charles & Colvard Ltd's EBITDA?

Charles & Colvard Ltd (CTHR) had EBITDA of -$13.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Charles & Colvard Ltd's gross margin?

Charles & Colvard Ltd (CTHR) had a gross margin of 23.6% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Charles & Colvard Ltd's operating margin?

Charles & Colvard Ltd (CTHR) had an operating margin of -66.5% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Charles & Colvard Ltd's net profit margin?

Charles & Colvard Ltd (CTHR) had a net profit margin of -65.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Charles & Colvard Ltd's return on equity (ROE)?

Charles & Colvard Ltd (CTHR) has a return on equity of -56.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Charles & Colvard Ltd's free cash flow?

Charles & Colvard Ltd (CTHR) recorded an outflow of $8.3M in free cash flow during fiscal year 2024. This represents a -63.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Charles & Colvard Ltd's operating cash flow?

Charles & Colvard Ltd (CTHR) recorded an outflow of $7.4M in operating cash flow during fiscal year 2024, representing cash used by core business activities.

What are Charles & Colvard Ltd's total assets?

Charles & Colvard Ltd (CTHR) had $41.0M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Charles & Colvard Ltd's capital expenditures?

Charles & Colvard Ltd (CTHR) invested $954K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How many shares does Charles & Colvard Ltd have outstanding?

Charles & Colvard Ltd (CTHR) had 3M shares outstanding as of fiscal year 2024.

What is Charles & Colvard Ltd's current ratio?

Charles & Colvard Ltd (CTHR) had a current ratio of 1.33 as of fiscal year 2024, which is considered adequate.

What is Charles & Colvard Ltd's debt-to-equity ratio?

Charles & Colvard Ltd (CTHR) had a debt-to-equity ratio of 0.60 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Charles & Colvard Ltd's return on assets (ROA)?

Charles & Colvard Ltd (CTHR) had a return on assets of -35.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

How does Charles & Colvard Ltd's liquidity compare with its operating cash outflow?

At the end of fiscal year 2024, Charles & Colvard Ltd (CTHR) held $4.1M in cash, cash equivalents and investments, and reported an operating cash outflow of $7.4M over that year. Dividing the one by the other, the reported balance equals about 7 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Charles & Colvard Ltd's Piotroski F-Score?

Charles & Colvard Ltd (CTHR) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Charles & Colvard Ltd's earnings high quality?

Charles & Colvard Ltd (CTHR) reported a net loss of $14.4M while operations used $7.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Charles & Colvard Ltd cover its interest payments?

Charles & Colvard Ltd (CTHR) reported an operating loss of $14.6M against $58K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.